Supply Chain Ecosystem Analysis now part of DBMR Reports
Market Size in USD Billion
| 2022 –2029 | |
|
|
USD 56.10 Billion |
| USD 97.84 Billion | |
| % | |
|
Global Kinase Inhibitors Market, By Type (Tyrosin Kinase Inhibitors, Mulikinase Inhibitors, mTOR Kinase Inhibitors, Others), Route of Administration (Oral, Parenteral, Others), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy) – Industry Trends and Forecast to 2029.
The kinase inhibitors market is expected to witness significant growth during the forecast period. The dynamic field of cancer R&D is permitting an improvement to the specialization in kinases, which play an essential role as mediators in many types of cancer and other diseases. Latest advancements are being made in anti-angiogenesis receptor tyrosine kinase inhibitors used for cancer treatment. Several companies are growing their efficacy in molecular modeling to accelerate drug discovery for fibrosis and other diseases. COVID-19 also had a major impact on the market growth.
Data Bridge Market Research analyses a growth rate in the global kinase inhibitors market in the forecast period 2022-2029. The expected CAGR of global kinase inhibitors market is tend to be around 7.2% in the mentioned forecast period. The market was valued at USD 56.1 billion in 2021, and it would grow upto USD 97.84 billion by 2029. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
|
Report Metric
|
Details
|
|
Forecast Period
|
2022 to 2029
|
|
Base Year
|
2021
|
|
Historic Years
|
2020 (Customizable to 2014 - 2019)
|
|
Quantitative Units
|
Revenue in USD Billion, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Type (Tyrosin Kinase Inhibitors, Mulikinase Inhibitors, mTOR Kinase Inhibitors, Others), Route of Administration (Oral, Parenteral, Others), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
|
|
Market Players Covered
|
Novartis AG (Switzerland), Endo International Inc (Ireland), Teva Pharmaceutical Industries Ltd (Israel), Glenmark Pharmaceuticals Ltd (India), Cipla Inc (India), Dr Reddy's Laboratories Ltd (India), Abbott (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), Pfizer Inc (U.S.), Lupin (India), Takeda Pharmaceutical Company Limited (Japan), Akorn, Incorporated (U.S.) Torrent Pharmaceuticals Ltd. (India), Amneal Pharmaceuticals LLC. (U.S.), Astellas Pharma Inc. (Japan), Sierra Oncology, Inc (Canada)
|
|
Market Opportunities
|
|
Market Definition
Kinase inhibitors are the drug class that restricts the action of kinases by adding a phosphate group to protein so that function of kinase gets disrupted. Kinases are involved in several cellular activities, including cell proliferation, differentiation, cell cycle, and cell apoptosis. Their inhibition can negatively impact a cell, causing it to die or fail to function properly. Most important types are therefore used to treat a diversity of diseases where this type of disruption is important to be involved, such as cancer, diabetes, and inflammation.
Drivers
The kinase inhibitors market is projected to expand during the forecast period. Innovations such as artificial intelligence are transforming the market for kinase inhibitors. For instance, the U.S. biotechnology startup Insilico Medicine revealed its deep learning system, which can identify potential treatments for fibrosis with the help of DDR1 (Discoidin Domain Receptor 1) kinase inhibitors. Besides this, several healthcare companies are capitalizing on generative adversarial networks (GANs) to produce novel molecular structures with specified properties. Similarly, deep learning is letting companies with the rapid identification of potent DDR1 kinase inhibitors. Thus, all these advancements lead to the market growth.
Rise in the occurrence of cancer patients among the population is the primary cause of the growth of the global kinase inhibitors market. As per the Cancer Research UK data, about 17 million new cancer cases were reported globally in 2018 and almost 27.5 million new cancer cases are likely to be observed worldwide by 2040. Thus, this increasing prevalence of cancer is demanding more kinase inhibitors and which in return is boosting the market growth.
Opportunities
Novel assays and profiling techniques are serving companies to develop improved kinase inhibitors for drug development. The discovery of new kinase inhibitors is projected to improve biochemical, cellular, and in vivo assays that are assisting in offering new therapeutic targets. Companies in the kinase inhibitors market are growing R&D to gain expertise in cell signaling for the huge development of new drugs. Several companies are making more and more efforts to gain information on biochemical and biophysical assays to study the potency and selectivity of kinase inhibitors. Thus, these developments are creating huge efforts for the market expansion.
Increasing indications of existing and pipeline kinase inhibitors also create many opportunities for market growth. For instance, BCR-ABL TKIs, which were earlier approved for treating CML, are now indicated to treat acute lymphoblastic leukemia (ALL) and gastrointestinal tumors. Likewise, EGFR TKIs are approved for a collection of indications such as pancreatic cancer, breast cancer, and non-small cell lung cancer.
Restraints/Challenges
The lack of qualified personnel who are unable to treat the patients with appropriate treatments could limit the growth of the global kinase inhibitors market over a forecast period.
The R&D has higher costs and complex approval processes by respective governments, which restricts the market's growth significantly. Furthermore, the high development cost of drugs causes the higher market price of the drug post-approval. Therefore, the cost of the treatment has been limiting the market growth up to a certain level.
This kinase inhibitors market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the kinase inhibitors market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
COVID-19 has left a major global public health crisis which has impacted practically every business. Shift from healthcare infrastructure towards managing COVID-19 has led to drug launch withdrawals and delays in clinical trials.
In the post-pandemic era, the biotechnology and pharmaceutical industries are estimated to witness enormous future growth due to the demand for vaccine and treatment drugs for COVID-19. It has been witnessed that the non-receptor tyrosine kinase inhibitors result in the highest revenue share of the market in 2021 and are projected to lead the market in the post-COVID-19 period due to their high effectiveness in the treatment of autoimmune and inflammatory skin diseases such as rheumatoid arthritis.
Recent Developments
The global kinase inhibitors market is segmented on the basis of type, route of administration, distribution channel and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Type
Route of Administration
End User
Distribution Channel
The global kinase inhibitors market is analysed and market size insights and trends are provided by type, route of administration, distribution channel and end-user as referenced above.
The major countries covered in the global kinase inhibitors market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America has been witnessing a positive growth for global kinase inhibitors market throughout the forecasted period due to the increase prevalence of cancer and large availability of treatment options for cancer patient.
Asia-Pacific dominates the market due to the government funding and awareness.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
The global kinase inhibitors market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to global kinase inhibitors market
Key players operating in the global kinase inhibitors market include:
SKU-
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.